Detalhe da pesquisa
1.
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
J Antimicrob Chemother
; 77(11): 3035-3038, 2022 10 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35971759
2.
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
J Antimicrob Chemother
; 77(12): 3414-3420, 2022 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36177825
3.
Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci.
J Clin Microbiol
; 59(12): e0163521, 2021 11 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34495708
4.
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
J Antimicrob Chemother
; 76(7): 1808-1814, 2021 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33792700
5.
Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods.
J Clin Microbiol
; 58(10)2020 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-32817224
6.
In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30397056
7.
Characterization of MRSA in Canada from 2007 to 2016.
J Antimicrob Chemother
; 74(Suppl 4): iv55-iv63, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505646
8.
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
J Antimicrob Chemother
; 74(Suppl 4): iv64-iv71, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505647
9.
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
J Antimicrob Chemother
; 74(Suppl 4): iv22-iv31, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505648
10.
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
J Antimicrob Chemother
; 74(Suppl 4): iv5-iv21, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505641
11.
In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.
Antimicrob Agents Chemother
; 58(2): 1252-6, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24323476
12.
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Antimicrob Agents Chemother
; 57(11): 5600-11, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23979759
13.
CHROMagar Orientation medium reduces urine culture workload.
J Clin Microbiol
; 51(4): 1179-83, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23363839
14.
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
J Antimicrob Chemother
; 68 Suppl 1: i39-46, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587777
15.
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.
J Antimicrob Chemother
; 68 Suppl 1: i47-55, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587778
16.
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.
J Antimicrob Chemother
; 68 Suppl 1: i23-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587775
17.
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
J Antimicrob Chemother
; 68 Suppl 1: i31-7, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587776
18.
Molecular epidemiology of extended-spectrum ß-lactamase-, AmpC ß-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
J Antimicrob Chemother
; 68 Suppl 1: i57-65, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587779
19.
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.
J Antimicrob Chemother
; 68 Suppl 1: i7-22, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587781
20.
Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time.
J Clin Microbiol
; 50(10): 3324-8, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22875888